Kindly (KDL) Group was established in 1987, mainly engaged in manufacturing, R&D, sales and trade of medical puncture device. KDL Group is the first company passed CMDC certificate in medical devices industry in 1998 and got EU TUV certificate and passed American FDA on site audit. Over 30 years, KDL Group was successfully listed on the main board of the Shanghai Stock Exchange on 2016 (Stock code SH603987) and have more than 66 wholly-owned and majority-owned subsidiaries. The subsidiaries are located in Central China, Southern Chin, Eastern China and Northern China.

Kindly (KDL) Group established the diversified and professional business pattern with advanced medical products and service in the field of syringes, needles, tubings, IV infusion, diabetes care, intervention devices, pharmaceutical packaging, aesthetic devices, veterinary medical devices and specimen collection, and active medical devices under the company’s policy “Concentrating on the Development of Medical Puncture Device”, it has been developed into one of the manufacturing enterprises with complete industrial chain of medical puncture devices in China.